

HY-141600 · 1 mg
MedChemExpress · Cat: HY-141600
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/aprutumab-ixadotin.html
Description
Aprutumab ixadotin BAY 1187982 is the first antibody-drug conjugate ADC to target FGFR2 and the first to use Auristatin-based payload. Aprutumab ixadotin contains a fully human anti-FGFR2 monoclonal antibody Aprutumab HY-P99007 conjugated by lysine side chains to a non-cleavable linker and via this an innovative Auristatin W derivative. Aprutumab ixadotin can be used for the study of advanced solid tumors, such as FGFR2-positive gastric cancer and triple-negative breast cancer.







